Login
$AVXL
$0.83 +$0.01 (1.52%) After hours

$AVXL SEC Filings

Filed On Filing
06 Nov 2026 Form 4: Velden Claus Vander, Director

Granted 50,000 Stock Option (Right to Buy)

06 Nov 2026 Form 4: Donhauser Peter D.o., Director

Granted 50,000 Stock Option (Right to Buy)

06 Nov 2026 Form 4: Kellmeyer Terrie, Director

Granted 200,000 Stock Option (Right to Buy)

06 Nov 2026 Form 4: Paeger Axel, Director

Granted 50,000 Stock Option (Right to Buy)

03 Nov 2026 8-K: Departure/Election of Directors or Officers; Compensation

Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors

02 Nov 2026 8-K: Departure/Election of Directors or Officers; Compensation; Other Events

I write to inform you of my decision to resign from my position as a member of the Board of Directors of Anavex Life Sciences, where I am the chairman of the Board; and a member of the Audit Committee. My resignation is effective on Octo...

20 Oct 2026 8-K: Other Events

Clinical conduct of both blarcamesine (ANAVEX®2-73) studies in healthy volunteers is now complete, data are expected to support clinical pharmacology characterization across pipeline programs

15 Oct 2026 8-K: Other Events

Anavex now has open INDs in all three core indications: Alzheimer’s disease, Rett syndrome, and Fragile X syndrome

05 Oct 2026 Form 3: Senderowicz Adrian, Director

No securities owned

05 Oct 2026 Form 3: Patel Gautam, Director

No securities owned

28 Sep 2026 Form 4: Boenisch Sandra, PFO & Treasurer

Granted 95,000 Stock Option (Right to Buy)

28 Sep 2026 8-K: Changes in Control of Registrant; Submission of Matters to a Vote of Security Holders

As further described under Item 5.07 of this Current Report on Form 8-K, Anavex Life Sciences Corp. (“Anavex” or the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on September 24, 2026. The election of th...

21 Sep 2026 DFAN14A
18 Sep 2026 DFAN14A
17 Sep 2026 DFAN14A
15 Sep 2026 FORM DEFA14A
15 Sep 2026 DFAN14A
14 Sep 2026 FORM DEFA14A
10 Sep 2026 DFAN14A
10 Sep 2026 DFAN14A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support